CPT code 96570 represents photodynamic therapy administered to abnormal tissue during the same session as a primary endoscopy or bronchoscopy to destroy cancerous or precancerous cells. This adjunctive, procedure-based therapy combines a photosensitizing agent with controlled light exposure and is used when lesions are accessible via endoscopic or bronchoscopic approaches. Nationally, the code matters for facilities and providers that deliver endoscopic oncology interventions and for payers that manage coverage for adjunctive cancer therapies.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context and coding scope, typical sites of service, common modifiers and billing considerations, and where to look for related codes and documentation needs. The publication also summarizes benchmarks and policy-relevant items when available and identifies gaps labeled as "Data not available in the input" when specific payer policies, related ICD-10 diagnoses, taxonomies, or service-line allocations are not provided in the source data.

This brief equips coding professionals, revenue cycle managers, and clinical leaders with a concise reference to the clinical intent of CPT code 96570, expected service settings, and the payer landscape covered in the analysis.